Plexpcr
1 known investors
SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers. The company serves laboratories, diagnostic companies, biotechs, and pharmaceutical firms through technology licensing, custom assay development, and partnership services.